Tumor Biology

, Volume 35, Issue 5, pp 4659–4665 | Cite as

Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking

  • Xiaoyu Li
  • Jing Xu
  • Xinxin Yang
  • Yungang Wu
  • Baohua Cheng
  • Dongfeng Chen
  • Bo Bai
Research Article


We investigated the potential association of 12 single nucleotide polymorphisms (SNPs) of nucleotide excision repair (NER) genes with risk of laryngeal cancer. A ratio of 1:1 matched case–control study was conducted. Conditional regression analysis indicated that subjects with ERCC1 rs11615 CC and C allele had an increased risk of laryngeal cancer compared with the TT genotype. Individuals with the ERCC5 rs17655 GG and G allele had a moderately increased risk of laryngeal cancer when compared with the CC genotype. By stratified analysis, ERCC1 rs11615 CC genotype and C allele were significantly associated with greatly increased risk of laryngeal cancer in ever smokers. ERCC1 rs11615 and ERCC5 rs17655 polymorphisms were associated with a moderately increased risk of this cancer in ever drinkers. In summary, we suggest that genetic variations in ERCC1 rs11615 and ERCC5 rs17655 are associated with laryngeal cancer risk in a Chinese population, especially in ever smokers and drinkers. Our finding could be helpful in identifying people at high risk for the disease for early intervention.


Single nucleotide polymorphism Laryngeal cancer DNA repaired gene 



This work was supported by the Shandong Provincial Natural Science Foundation of China (ZR2010HL045, ZR2010HL057), the Jining City Science and Technology Development Plan Program of the Jining Science and Technology Bureau (2012jnfs02, 2012jnfs11, 2012jnfs13), the Youth Fund of Jining Medical University (JYQ2011KZ005), and the Shandong Province Higher Educational Science and Technology Program (J12LE10).

Conflicts of interest



  1. 1.
    GLOBOCAN 2008. International Agency for Research on Cancer (Online) Available at: Accessed on 28th May 2011.
  2. 2.
    Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, Chen ZT. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol. 2009;135:1081–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Vassileiou A, Vlastarakos PV, Kandiloros D, Delicha E, Ferekidis E, Tzagaroulakis A, et al. Laryngeal cancer: smoking is not the only risk factor. B-ENT. 2012;8(4):273–8.PubMedGoogle Scholar
  4. 4.
    Wang J, Gao J, Li Y, Zhao X, Gao W, Peng L, et al. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Gene. 2013;524(2):193–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control. 2002;13(10):957–64.CrossRefPubMedGoogle Scholar
  6. 6.
    Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007;6(7):923–35.CrossRefGoogle Scholar
  7. 7.
    Longhese MP, Mantiero D, Clerici M. The cellular response to chromosome breakage. Mol Microbiol. 2006;60(5):1099–108.CrossRefPubMedGoogle Scholar
  8. 8.
    Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, et al. Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci. 2012;8(6):1065–75.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, et al. Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol. 2010;89(3):358–66.CrossRefPubMedGoogle Scholar
  10. 10.
    Weber A, Tannapfel A, Wittekind C, Bootz F. Carcinogen-induced site-specific mutagenesis and genetic susceptibility in squamous cell carcinoma of the head and neck. Onkologie. 2002;25(1):8–13.PubMedGoogle Scholar
  11. 11.
    Flores-Obando RE, Gollin SM, Ragin CC. Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers. 2010;15(5):379–99.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Sliwinski T, Markiewicz L, Rusin P, Kabzinski J, Dziki L, Milonski J, et al. Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer. Mutat Res. 2011;716(1–2):51–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer. 2009;125:1431–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao J, Cao W, et al. Polymorphism of xeroderma pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer. 2006;118:714–20.CrossRefPubMedGoogle Scholar
  15. 15.
    Larynx. In: Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010. pp. 57–62.Google Scholar
  16. 16.
    Shannon M, Lamerdin JE, Richardson L, McCutchen-Maloney SL, Hwang MH, et al. Characterization of the mouse XPF DNA repair gene and differential expression during spermatogenesis. Genomics. 1999;62:427–35.CrossRefPubMedGoogle Scholar
  17. 17.
    Jones AR, Bell-Horwath TR, Li G, Rollmann SM, Merino EJ. Novel oxidatively activated agents modify DNA and are enhanced by ercc1 silencing. Chem Res Toxicol. 2012;25:2542–52.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Yin J, Vogel U, Ma Y, Wang H, Wang C, Liang D, et al. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. Lung Cancer. 2012;76:286–91.CrossRefPubMedGoogle Scholar
  19. 19.
    Zhang N, Lin LY, Zhu LL, Wu F, Wen H, Pan D, et al. ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case–control study. Cancer Invest. 2012;30:199–202.CrossRefPubMedGoogle Scholar
  20. 20.
    Yang Z, Fang X, Pei X, Li H. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population. Genet Test Mol Biomark. 2013;17:700–6.CrossRefGoogle Scholar
  21. 21.
    Chu H, Gu D, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Rumiato E, Cavallin F, Boldrin E, Cagol M, Alfieri R, Basso D, et al. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Pharmacogenet Genomics. 2013;23(11):597–604.CrossRefPubMedGoogle Scholar
  23. 23.
    Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, et al. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell. 2000;101:159–71.CrossRefPubMedGoogle Scholar
  24. 24.
    Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci. 2007;4:59–71.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    International Agency for Rescarch on Cancer, World Health Organization. Alcohol drinking. Lyon: World Health Organization, International Agency for Research on Cancer; 1988. p. 8.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Xiaoyu Li
    • 1
  • Jing Xu
    • 2
  • Xinxin Yang
    • 1
  • Yungang Wu
    • 1
  • Baohua Cheng
    • 3
  • Dongfeng Chen
    • 4
  • Bo Bai
    • 5
  1. 1.Department of Otolaryngology Head and Neck SurgeryThe Affiliated Hospital of Jining Medical UniversityJiningChina
  2. 2.The Affiliated Hospital of Jining Medical UniversityTianjinChina
  3. 3.Department of AnatomyJining Medical UniversityJiningChina
  4. 4.Department of UltrasoundThe Affiliated Hospital of Jining Medical UniversityJiningChina
  5. 5.Department of PhysiologyJining Medical UniversityJiningChina

Personalised recommendations